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The octadecapeptide amide I and the tetracosapeptide II containing homoarginine in position 8 have been synthesized according to a generally approved scheme. As a new feature, the hydroxyl functions of the serine and tyrosine residues were protected in the synthesis of the iV-terminal decapeptide. The latter, presumably by its higher solubility in organic solvents, afforded the protected end products in an improved yield. For complete deprotection, however, acid-treatment of these compounds had to be extended over longer periods than in the absence of the ether functions.
Introüuction
The adrenal cortex and fat cells are stimulated to either steroidogenesis or lipolysis by the adenohypophysal hormone ACTH, which is composed of 39 amino acid residues. The aminoterminal part of this sequence comprising 24 amino acid residues also displays full biological activity and even the shorter sequence covering the aminoterminal octadecapeptide suffïces to exert the effects mentioned. Apparently, all structural requirements essential for biological activity are present in the latter. On account of experiments, in which a competitive inhibitory action on stimulated steroidogenesis was ascribed to smaller ACTH fragments comprising the basic core (the sequence 15-18), the occurrence óf two indispensable loei was supposed by Schwyzer1 and by Hofmann2 in fully active corticotrophic peptides. According to their hypothesis, biological information is contributed by the sequence 5-10, whereas binding of the hormone is induced by the basic sequence. Consequently, the purport of these two "sychnological words"3 should be of differing importance.
Our previous investigations on ACTH-analogues in which arginyl residues were replaced by omithyl groups fit very well into this hypo thesis: a) the single replacement of arginine in position 8 by omithine4 reduced the biological activity to a very low level; b) similar substitutions of the basic core, however, did not affect steroidogenesis and lipolysis5a and even replacement of the entire sequence 15-18 by tetraomithine failed to influence the hormonal abüity of the analogue profoundly5b.
Recently, with the analogues I and II we found that substitution in position 8 by homoarginine leads to compounds exhibiting a surprising activity on steroidogenesis and lipolysis in in vitro and in vivo experiments6. The analogues I and II* are to be considered as derivatives of the weakly potent analogues that arise upon insertion of lysine7 or ornithine in position 8. The aim of this communication is the description of the underlying syntheses.
(I) H-Ser-Tyr-Ser-Met-Glu-His-Phe-//ar-Trp-Gly-Lys-Pro-Val-Lys-Lys-Lys-Lys-NH2
(II) H-Ser-Tyr-Ser-Met-Glu-His-Phe-i/ar-Trp-Gly-Lys-Pro-Val-Lys-Lys-Arg-Arg-ProVal-Lys-Val-Tyr-Pro-OH
Synthetic Approach
In accordance with the general procedure recommended for the syn thesis of corticotrophic peptides9, the end products I and II were obtained in protected form by a carbodiimide mediated coupling, generating the glycyl-lysyl bond between the N-terminal decapeptide and the pertinent C-terminal fragments. Key intermediate in this investigation was the delicate tetrapeptide ester Boc-Phe-Har(N02)-Trp-Gly-OMe (V, Scheme 1). The best way for its preparation turned out to be a fragment condensation using Mitin's method 10. Configurational homogeneity was confirmed by a second synthesis, in which the danger of racemization was greatly eliminated by use of the stepwise technique. All intermediates resisted crystallization, tended strongly to discoloration and had to be purified by countercurrent distribution. Physical data revealed that the purifïed products from the two routes were identical.
From this tetrapeptide ester, by two succesive acylations with Z-Glu(OBu')-His-N3 and either Boc-Ser-Tyr-Ser-Met-N3 or its tristert-butyl ether, the decapeptide (common to both end products) was 
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Boc-Phe-Har(N02)-Trp-Gly-()Me (V)
By fragment condensation a) Boc-Phe-Har(N02)-O H (III)
. A^-Nitrohomoarginine12 was esterified with metha nol by refluxing a 1 0 % solution of the amino acid with a mixture of thionyl chloride chloride and methanol (1:10 v/v prepared at -15°) for 2 j h. After evaporation of the mixture and some additional evaporations with methanol to remove volatile byproducts, Acylation to the dipeptide ester was performed in dimethylformamide with Boc-Phe ONSu13 after careful neutralisation of the total amount of chloride present. A 10% molar excess of the amino component was used to ensure complete conversion of the activated ester. After 3 h. at room temperature, the reaction mixture was filtered and concentrated to a thick syrup which was diluted with water to give an oily precipitate.
The aqueous layer was separated, extracted with ethyl acetate and discarded. The organic phase was added to the oil and the solution was extracted with citric acid, bicarbonate, and sodium chloride solutions and dried.
The product resisted crystallization. A thin layer chromatogram showed a single spot with chlorine-tolidine coinciding with that observed by fluorescense quenching on silica. Rf = 0.73 (butanol-acetic acid-water = 10: 1:3); no starting material remained.
Alkaline hydrolysis of the dipeptide ester again gave a resinous product III exhibiting an Rf value of 0.67 in the same solvent system. It was free from methyl ester.
b) H-Trp-Gly-OMe, HCl (IV ). 8.2 (20 mmoles) of Z-Trp-Gly-OMe14 were suspended in 80 ml of methanol and hydrogenated in the presence of 500 mg of palladium/charcoal (10%) and 1.82 ml (22 mmoles) of aqueous concentrated HCl. During the uptake of hydrogen (480 ml in about 20 min), the ester went into solution. Then 2.5 ml of pyridine were added (to prevent acid catalysed oxidative detoriation) and the catalyst was removed by filtration. The solid remaining after evaporation of the solvent was extracted with warm isopropanol. The off-white, noncrystalline salt was kept in the dark. Yield: 6.2 g (quantitative) of chromatographically pure IV, TS : RF = 0.28 (f-amylalc -isopropanol -water = 67:26:7) = 0.51 (n-BUOH-AcOH-water = 48: 5: 14). 56.98; 6.62; 17.09.
H -Phe-H ar(N02)-Trp-GIy-0Me (V I).
7.38 g (10 mmoles) of the former product were deprotected with methanolic HC1 as described for the corresponding tripeptide ester. Evaporation in vacuo left a dark oil. The ester hydrochloride was converted into the free amine by the procedure given by Schwyzer16. The resulting yellow solid was dried in air yielding 5.35 g (84%) of VI. The free base could be converted into a crystalline salt by treatment of its methanolic solution ( 2 0 %) with oxalic acid in methanol .Again a brown oil separated, which crystallized upon cooling in the refrigerator overnight. The solid was again dissolved in methanol, enough to give a 4% solution and reprecipitated by addition of isopropanol. Repetition of this procedure yielded an analytically pure product. TS : RF = 0.27 (BuOH -AcOH -water = 1 0 :1 :3 ); [a]jj5 = -10.3 (c = 1, MeOH).
Part of this material was subjected to countercurrent distribution over 240 transfers. The product migrated as a single peak in the system n-butanol-petroleum ether (60-80)-acetic acid -water = 4: 1 : 1 :4 (K = 0,54 and rmax = 27). It was isolated by lyophiliza tion from /erf.-butanol.
Found
: C 58.9 ; H 5.7 ; N 17.25. Calc. for C 3 0 H 3 9 N 9 O 7 -C2 H 2 0 4 : 58.82; 5.68; 17.32.
Z-G lu(0Bu')-H is-Phe-H ar(N02)-Trp-Gly-0H (V II).
Acylation of the tetrapeptide ester VI with benzyloxycarbonyl-y-ferf-butoxyglutamyl-histidine azide was carried out with slight modifications according to Schwyzer16; tert-baty\ nitrite was used as the source of nitrosonium ions as described by Honzl and Rudinger17 and the azide was used in situ. The crude hexapeptide ester was produced in nearly quantitative yield and was hydrolyzed without further characterization by alkaline saponifïcation. The free acid VII appeared to be more readily soluble than the corresponding peptide derivative containing nitroarginine16: it precipitated incompletely on acidification of the alkaline reaction mixture. By concentration of the mother liquor, however, a second precipitate was obtained giving a total yield of 80 % based on the amount of tetrapeptide ester used. Although no contaminants could be detected on TLC, the product stubbornly resisted complete hydrogenolysis in the next step, unless purifïed by countercurrent distribution. In the solvent system CHC13 -MeOH -CC14 -buffer (7 :1 0 : 2 ; 4) after 115 transfers, the compound was located in the elements 55-80 (K = 1.4rmax = 67). The purifïed product VII melted at 201-204° [<x]ë5 = 11.4° (c = 1.03 in AcOH 90%); = -2 3 .6 (c = 2, DMF). TS : RF = 0.34 (BuOH -AcOH -water = 10 :1 : 3); = 0.34 (<-amyl alcohol -isopropanol-water = 5 1 :2 1 :2 8 ); = 0.56 (s-BuOH -AcOH -water = 67 :10 : 23); = 0.27 (E tO A c -P y r-A c O H -w a te r = 62 : 21: 6 :11).
H-Glu(OBul) -His-Phe-Har-Trp-Gly-OH (IX ) .
For the removal of iV-protecting groups, the hexapeptide derivative VII was dissolved in peroxide-free acetic acid (90%) and hydrogenated in the presence of palladium charcoal (10 %). Apparently, hydrogenolysis of the benzyloxycarbonyl group proceeded much faster than that of the nitro group: following the progress of the reaction chromatographically on Kieselgel-G (Merck) in methanol, the protected peptide (RF = 0.8) appeared to be converted into an intermediate (RF = 0.5) containing the nitroguanidino function before the end product (RF = 0.2) arose. After 30 hours the reaction was complete and slightly more than the theoretical amount of hydrogen had been taken up. The solution was fïltered, the solvent evaporated and the residue dissolved in methanol. Dilution with ether gave the partially protected hexapeptide IX in nearly quantitative yield. 
Boc-Ser-Tyr-Ser-Met-Glu(OBu')-His-Phe-Har-Trp-Gly-OH (Xa).
According to Schwyzer's procedure16, this compound was synthesized from 0.60 g (1 mmole) of Boc-Ser-Tyr-Ser-Met-N2 H3 and 0.68 g (0.71 mmole) of the hexapeptide derivative IX, using sodium nitrite. The yield, after crystallization from hot 90% methanol was 0.53 g (51 %); M è 2 = -16 .4° (c = 0.7 AcOH); TS (Kieselgel-G, Merck): RF = 0.25 (B u O HAcOH -water = 10 :1 : 3).
Boc-Ser(Bu1) -Tyr(B it')-Ser(B u')-M et-G lu(O Bu1)-His-Phe-Har-Trp-Gly-OH (Xb).
1.04 g (1.36 mmole) of the protected tetrapeptide hydrazide (XVIII, scheme 2) was .onverted into the corresponding azide VUIb and coupled with 1.3 g (1.36 mmole) of the hexapeptide tert-butyl ester acetate according to Honzl and Rudinger's general insitu procedure17. The yield was 1.80 g (76%); T S : RF = 0.33 (BuOH-AcOHwater = 1 0 :1 : 3), = 0.36 (BuOH -A cO H -water = 67 :10 : 23), = 0.50 (jec-BuOHisopropanol-9 % monochloroacetic acid = 58 : 8 : 34), = 0.70 («-BuOH -Pyr-AcOH water = 38 : 24: 8 : 30); [a]ê° = -14.5° (c = 1, MeOH). The Tyr/Trp ratio (0.9) after treatment with 90% TFA during 15 minutes points to the presence of about 5 % of the hexapeptide in the crude decapeptide derivative. It was used as such for the preparation of XX and XXII. A sample (100 mg) was subjected to the "short column" chromatographic technique of Hunt and Rigby1S. With the solvent system butanol -acetic acidwater (67 :10: 23) at a pressure of 30 cm of mercury chromatographically pure material (67 mg) was eluted in a sharp band comprising about 2 ml. Even a trace of decapeptide derivative containing oxidized methionine in position 4 was retained. The product gave a correct Tyr/Trp ratio.
Scheme 2. Z-Tyr(Bul)-Ser(Bu')-O M e (X I).
2.76 g of jV-Benzyloxycarbonyl-O-ferZ-butyltyrosine dicyclohexylammonium salt19 (5 mmoles) and 1.06 g of 0-/erf-butylserine methyl ester monohydrochloride (from the corresponding benzyloxycarbonyl compound18, after hydrogenolysis and acidifïcation with etheral HC1) were dissolved in 30 ml of chloroform. The solution was cooled to 0° and 1.03 g (5 mmoles) of dicyclohexylcarbodiimide were added.
The reaction mixture was left in a refrigerator for 16 hours and filtered. The fïltrate was evaporated in vacuo, the residue triturated with ether, filtered and the solvent was again removed in vacuo. The crude, crystalline dipeptide ester was dissolved in ethyl acetate and its solution extracted with water, citric acid solution (5%), saturated bicarbonate solution and dried. The product was further purified by crystallization from ether by the addition of petroleum ether (60- 
Boc-Ser(Bu')-Tyr(Bu') -Ser(Bu') -N2H 3 (X IV ).
a) Methyl ester (X III). 2.73 g (5.16 mmoles) of the preceeding compound were rapidly hydrogenated in methanol using 300 mg of palladium/charcoal (10%). The uptake of hydrogen stopped abrubtly when 125 ml had been absorbed (100 %). An equivalent amount of iV-butyloxycarbonyl-O-ïerf-butylserine18 was added to the filtered methanolic solution. Subsequently the mixture was evaporated to dryness, the residue dissolved in dimethylformamide (about 15 ml) containing 0.56 g of iV-hydroxysuccinimide and the solution cooled to -10°C. Then, with stirring, 1.03 g (5 mmoles) of dicyclo hexylcarbodiimide were added. Stirring was continued at -10° during 2 hours before the reaction mixture was placed in the refrigerator. After 16 hours, the cold solution was filtered and evaporated in vacuo. The residue, upon dissolution in ethyl acetate, deposited a small amount of dicyclohexylurea which was removed by fïltration. The filtrate was extracted with water, citric acid and bicarbonate solution as above and, after drying. left the product as an oil on evaporation. It changed into a crisp foam upon drying ii high vacuum and proved chromatographically pure TS : RF = 0.78 (chloroform -ben zene = 1:1). Yield: 94.2%. b) Hydrazide (X IV ). 2.85 g (4.5 mmoles) of the methyl ester were dissolved in 15 ml of methanol, containing 1.46 ml (13.5 mmoles) of hydrazine hydrate and left for three days at room temperature. The hydrazide crystallized upon addition of water and appeared pure on TLC. It was dried in a vacuum desiccator over concentrated H 2 S 0 4. For analysis it was crystallized once from aqueous methanol, [a ] , 2, 3 = -3.0° (c = 1, MeOH).
Found
: C 59.8 ; H 8.5 ; N 11.0 . Calc. fo rC 32H 55N 50 8(637.80): C 60.26; H.8.69; N 10.98 .
Boc-Ser(But)-Tyr(B ui)-Ser(Bu')-M et-O M e (X V I
). 1.276 g (2 mmoles) of the foregoing protected hydrazide were dissolved in 2 0 ml of dimethylformamide, cooled to -30° and acidified with 5.5 mmoles of dry HC1 dissolved in peroxide-free dioxane (3.04 ml of a 1.81 TV-solution). 0.27 ml of tert-bxAyX nitrite was then added dropwise and the temperature was raised to -15°. After 10 minutes, the acid present was carefully neutralised by addition of 0.77 ml (5.5 mmoles) of triethylamine. To the azide solution, a cooled solution of 0.44 g of methionine methyl ester hydrochloride (2.2 mmoles) in 20 ml of dimethylformamide and finally 0.31 ml (2.2 mmoles) of triethylamine were added. The reaction mixture was left in the refrigerator for three days, filtered to remove triethylammonium chloride, and evaporated in a high vacuum. The residue was dissolved in peroxide-free ether and extracted with water, bicarbonate, citric acid, and concentrated sodium chloride solutions. Upon evaporation 1.44 g (93.5 %) of a foamy solid remained, melting at 100-102°. It was chromatographically pure. TS : RF = 0.86 (butanol -acetic acid-water = 4 :1 :1 ) ; M è 5 '2 = -7.3° (c = 1, MeOH). 
Scheme 3. Protected [Hars]-fi-corticotrophin-(l-24)-tetracosapeptides (XIX and XX) and [Har8, L ys11'1 s]-$-corticotrophin-(l-18)-octadecapeptide amide (XXII)
Condensation of the decapeptide derivatives Xa and b to the tetradecapeptide derivative XVIII9 and the acylation of the partially protected octapeptide amide XXI with Xb was performed by analogy with the procedure of Riniker20. The tetracosapeptide derivative XIX was purified by countercurrent distribution in the system CHCl3 -CCl4 -MeOH-buffer ( = 5 : 2 : 8 :4 -for buffer composition see under V). Vfter 250 transfers, pure material was located in the elements 55-76 (K = 0.34, rmM = 64). The yield was 44%. TS: RF = 0.26 (BuOH-AcOH-water = 10:1:3), = 0.30 (EtOAc-Pyr-AcOH-water = 6 2 :2 1 :6 :1 1 ). With the latter system, the presence of the corresponding sulphoxide derivate (RF = 0.20 about 5 %) was detected in the product.
The compounds XX and XXII, arising from the decapeptide derivative containing protected hydroxyl functions (Xb), were isolated in a nearly pure state on evaporation of the reaction mixture and treatment with ethyl acetate. Subsequent countercurrent dis tribution of the tetracosapeptide XX in the same system over 450 transfers (K = 0.02, rma, = 7), gave pure material in 70 % yield. T S : RF = 0.27 (EtOAc-Pyr-AcOH-water = 6 2 :2 1 :6:11), free from sulphoxide.
[a] £ 5 = 54° (c = 0.587, AcOH 80%).
The protected octadecapeptide amide XXII was purified in the same manner with the system CHCl3 -CCl4 -MeOH-buffer (7 :4 :1 0 :3 ), 222 transfers (K = 0.22, rmal = 40). Yield 75%. TS: RF = 0.63 (EtOAc-Pyr-AcOH-water = 6 2 :2 1 :6 :1 1 ), = 0.73 (CHCl3-MeOH = 3:1).
[« ]" = 29° (c = 0.770, AcOH 80%).
Deprotection of XIX, XX and XXII: [Har9, Lys' 7AS]-fi-corticotrophin-( 1-18)-ociadecapeptide amide (I) and [ Hars]-fi-corticotrophin-( 1-24)-tetracosapeptide (II)
Removal of the protective groups from the three compounds was effected with 90% trifluoroacetic acid. Prior to use, the reagent was distilled from pure methionine (250 mg/ 100 ml) under nitrogen, to ensure the absence of trace amounts of peroxides. The reaction was carried out in the dark at room temperature in an atmosphere of nitrogen.
Chromatographical estimation of the time required for the removal of the protective groups from the three compounds revealed that compound XIX was set free within 15 minutes as expected but that much longer times were necessary for the removal of all protective groups from XX and XXII. Both compounds gave two intermediates each which were believed to be the mono-and bis-tert-butyl ethers of the otherwise deprotected peptides. In the description of the chromatographic observations (see below) the spots corresponding to these compounds are referred to as "transient spots". Complete removal of the ether functions required 8 hours for compound XX and 6 hours for XXII.
Under the conditions specified, 50 mg batches of the latter compounds were depro tected. The reaction mixture was concentrated after the appropriate period and the pro duct was precipitated with anhydrous, peroxide-free ether. The solid trifluoroacetates were dissolved in 0 . 1 iV-acetic acid and filtered through a column containing a weak ion exchanger Merckll, acetate cycle. Eluate fractions were pooled till the Folin-Ciocalteux reaction became negative, the solution was lyophylized and the product dried in vacuo. The yields were 95 % for I and 93 % for II.
The chromatographic examinations with respect to the completeness of the deprotec tion and the occurrence of oxidation (of methionine in position 4) were carried out on hand-made alumina thin layer plates (TA: Alumina Camag, with 12% of gypsum added) after separation with the system BuOH-AcOH- . The spots were detected with the chlorine-tolidine test, after the plates had been sprayed with con centrated ammonia and dried (for removal of residual pyridine). 
